118 related articles for article (PubMed ID: 16099766)
21. Class-Specific Monoclonal Antibodies and Dihydropteroate Synthase in Bioassays Used for the Detection of Sulfonamides: Structural Insights into Recognition Diversity.
Li C; Liang X; Wen K; Li Y; Zhang X; Ma M; Yu X; Yu W; Shen J; Wang Z
Anal Chem; 2019 Feb; 91(3):2392-2400. PubMed ID: 30580515
[TBL] [Abstract][Full Text] [Related]
22. Additive effects of a two-amino-acid insertion and a single-amino-acid substitution in dihydropteroate synthase for the development of sulphonamide-resistant Neisseria meningitidis.
Qvarnström Y; Swedberg G
Microbiology (Reading); 2000 May; 146 ( Pt 5)():1151-1156. PubMed ID: 10832642
[TBL] [Abstract][Full Text] [Related]
23. Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents.
Zhao Y; Shadrick WR; Wallace MJ; Wu Y; Griffith EC; Qi J; Yun MK; White SW; Lee RE
Bioorg Med Chem Lett; 2016 Aug; 26(16):3950-4. PubMed ID: 27423480
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs.
Iliades P; Meshnick SR; Macreadie IG
Antimicrob Agents Chemother; 2005 Feb; 49(2):741-8. PubMed ID: 15673759
[TBL] [Abstract][Full Text] [Related]
25. Novel and potent inhibitors for dihydropteroate synthase of
Satuluri SH; Katari SK; Pasala C; Amineni U
J Recept Signal Transduct Res; 2020 Jun; 40(3):246-256. PubMed ID: 32098568
[TBL] [Abstract][Full Text] [Related]
26. Examination of intrinsic sulfonamide resistance in Bacillus anthracis: a novel assay for dihydropteroate synthase.
Valderas MW; Andi B; Barrow WW; Cook PF
Biochim Biophys Acta; 2008 May; 1780(5):848-53. PubMed ID: 18342015
[TBL] [Abstract][Full Text] [Related]
27. Probing the roles of non-homologous insertions in the N-terminal domain of Plasmodium falciparum hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase.
Rattanachuen W; Jönsson M; Swedberg G; Sirawaraporn W
Mol Biochem Parasitol; 2009 Dec; 168(2):135-42. PubMed ID: 19631695
[TBL] [Abstract][Full Text] [Related]
28. Protein promiscuity: drug resistance and native functions--HIV-1 case.
Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
[TBL] [Abstract][Full Text] [Related]
29. Folate synthesis in higher-plant mitochondria: coupling between the dihydropterin pyrophosphokinase and the dihydropteroate synthase activities.
Mouillon JM; Ravanel S; Douce R; Rébeillé F
Biochem J; 2002 Apr; 363(Pt 2):313-9. PubMed ID: 11931659
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure of the 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase•dihydropteroate synthase bifunctional enzyme from Francisella tularensis.
Pemble CW; Mehta PK; Mehra S; Li Z; Nourse A; Lee RE; White SW
PLoS One; 2010 Nov; 5(11):e14165. PubMed ID: 21152407
[TBL] [Abstract][Full Text] [Related]
31. Mutations and horizontal transmission have contributed to sulfonamide resistance in Streptococcus pyogenes.
Jönsson M; Ström K; Swedberg G
Microb Drug Resist; 2003; 9(2):147-53. PubMed ID: 12820799
[TBL] [Abstract][Full Text] [Related]
32. Dihydropteroate synthase based sensor for screening multi-sulfonamides residue and its comparison with broad-specific antibody based immunoassay by molecular modeling analysis.
Liang X; Li C; Zhu J; Song X; Yu W; Zhang J; Zhang S; Shen J; Wang Z
Anal Chim Acta; 2019 Mar; 1050():139-145. PubMed ID: 30661581
[TBL] [Abstract][Full Text] [Related]
33. Development of antibacterial conjugates using sulfamethoxazole with monocyclic terpenes: A systematic medicinal chemistry based computational approach.
Swain SS; Paidesetty SK; Padhy RN
Comput Methods Programs Biomed; 2017 Mar; 140():185-194. PubMed ID: 28254074
[TBL] [Abstract][Full Text] [Related]
34. Exploring the catalytic mechanism of dihydropteroate synthase: elucidating the differences between the substrate and inhibitor.
Chotpatiwetchkul W; Boonyarattanakalin K; Gleeson D; Gleeson MP
Org Biomol Chem; 2017 Jul; 15(26):5593-5601. PubMed ID: 28639657
[TBL] [Abstract][Full Text] [Related]
35. Deciphering the competitive inhibition of dihydropteroate synthase by 8 marcaptoguanine analogs: enhanced potency in phenylsulfonyl fragments.
Das BK; Chakraborty D
J Biomol Struct Dyn; 2022; 40(23):13083-13102. PubMed ID: 34581241
[TBL] [Abstract][Full Text] [Related]
36. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
Ma L; Borio L; Masur H; Kovacs JA
J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
[TBL] [Abstract][Full Text] [Related]
37. Computational insights into factor affecting the potency of diaryl sulfone analogs as Escherichia coli dihydropteroate synthase inhibitors.
Das BK; Pv P; Chakraborty D
Comput Biol Chem; 2019 Feb; 78():37-52. PubMed ID: 30497019
[TBL] [Abstract][Full Text] [Related]
38. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
Biswas S
J Postgrad Med; 2004; 50(1):17-20. PubMed ID: 15047993
[TBL] [Abstract][Full Text] [Related]
39. Structure-based design and development of functionalized Mercaptoguanine derivatives as inhibitors of the folate biosynthesis pathway enzyme 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Staphylococcus aureus.
Dennis ML; Chhabra S; Wang ZC; Debono A; Dolezal O; Newman J; Pitcher NP; Rahmani R; Cleary B; Barlow N; Hattarki M; Graham B; Peat TS; Baell JB; Swarbrick JD
J Med Chem; 2014 Nov; 57(22):9612-26. PubMed ID: 25357262
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the origins and spread of putative resistance-conferring mutations in Plasmodium vivax dihydropteroate synthase.
Hawkins VN; Suzuki SM; Rungsihirunrat K; Hapuarachchi HC; Maestre A; Na-Bangchang K; Sibley CH
Am J Trop Med Hyg; 2009 Aug; 81(2):348-55. PubMed ID: 19635897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
